- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/48 - Iso-indolesHydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Patent holdings for IPC class C07D 209/48
Total number of patents in this class: 775
10-year publication summary
|
66
|
69
|
61
|
52
|
50
|
41
|
35
|
38
|
30
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17967 |
19 |
| Amgen Inc. | 4445 |
11 |
| Cancer Research Technology Limited | 515 |
11 |
| FUJIFILM Corporation | 30653 |
10 |
| SHPP Global Technologies B.V. | 1105 |
9 |
| The Scripps Research Institute | 1345 |
8 |
| Siemens Medical Solutions USA, Inc. | 1469 |
7 |
| ExxonMobil Chemical Patents Inc. | 3760 |
7 |
| Arvinas Operations, Inc. | 247 |
7 |
| Boehringer Ingelheim International GmbH | 4488 |
6 |
| Wisconsin Alumni Research Foundation | 3902 |
6 |
| Astex Therapeutics Limited | 207 |
6 |
| Celgene Corporation | 1408 |
6 |
| SABIC Global Technologies B.V. | 4619 |
6 |
| The Trustees of Princeton University | 1273 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3016 |
6 |
| Vectus Biosystems Limited | 28 |
6 |
| Zeon Corporation | 4169 |
6 |
| Syngenta Participations AG | 1484 |
5 |
| Massachusetts Institute of Technology | 10290 |
5 |
| Other owners | 622 |